AMPHETAMINE SULFATE

Product NDC
71337-025
11-digit product format
713370025
Labeler code
71337
Product ID
71337-025_6c7f2ea6-a673-4e70-9a39-6067057fe6d7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
AMPHETAMINE SULFATE
Dosage form
TABLET
Route
ORAL
Labeler
Havix Group Inc d-b-a Aavis Pharmaceuticals
Application
ANDA212901
Marketing category
ANDA
Marketing start
2020-10-22
Marketing end
0000-00-00
Substance
AMPHETAMINE SULFATE
Active strength
10 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule
CII
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71337-025-012022-12-05C16284748780-1d6a99b39-cb6e-a426-e053-dadaa90af4c2c4f87199-e80e-46c1-8f98-e090126fb916
71337-025-012022-01-28C16284748780-1d6a99b39-cb6e-a426-e053-dadaa90af4c2c4f87199-e80e-46c1-8f98-e090126fb916

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71337-025-0171337002501100 TABLET in 1 BOTTLE (71337-025-01) 100 tablet2020-10-230000-00-00NoNoCurrent